Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449774 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 220
- Enrollment target
NCT00449774 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 220 participants.
The verdict
NCT00449774, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 220 participants
- Enrollment target
Study Summary
This study intends to demonstrate bioequivalence of two formulations, the effect of food and water on one formulation and safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
Interventions
- DRUG Lamotrigine IR tablets
- DRUG Lamotrigine ODT tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2007-05-07 |
| Est. Completion | 2007-06-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00449774
The ClinicalTrials.gov registry entry for NCT00449774 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lamotrigine IR tablets is the first listed.
NCT00449774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00449774 about?
NCT00449774 is a clinical study titled "Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers". This study intends to demonstrate bioequivalence of two formulations, the effect of food and water on one formulation and safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
What is the current status of trial NCT00449774?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 220 participants. The study started on 2007-05-07. Estimated completion is 2007-06-19.
What interventions are being tested in trial NCT00449774?
The interventions under investigation include: Lamotrigine IR tablets (DRUG), Lamotrigine ODT tablets (DRUG).
Who is sponsoring clinical trial NCT00449774?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.